171 related articles for article (PubMed ID: 19270812)
1. Comparisons between macroadenomas and microadenomas in Cushing's disease: characteristics of hormone secretion and clinical outcomes.
Hwang YC; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
J Korean Med Sci; 2009 Feb; 24(1):46-51. PubMed ID: 19270812
[TBL] [Abstract][Full Text] [Related]
2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
Woo YS; Isidori AM; Wat WZ; Kaltsas GA; Afshar F; Sabin I; Jenkins PJ; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242
[TBL] [Abstract][Full Text] [Related]
4. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
[TBL] [Abstract][Full Text] [Related]
5. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
6. Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomas.
Machado MC; Alcantara AE; Pereira AC; Cescato VA; Castro Musolino NR; de Mendonça BB; Bronstein MD; Fragoso MC
J Endocrinol Invest; 2016 Dec; 39(12):1401-1409. PubMed ID: 27363699
[TBL] [Abstract][Full Text] [Related]
7. Cyclic Cushing's disease with paradoxical response to dexamethasone.
Checchi S; Brilli L; Guarino E; Ciuoli C; Di Cairano G; Mazzucato P; Pacini F
J Endocrinol Invest; 2005 Sep; 28(8):741-5. PubMed ID: 16277172
[TBL] [Abstract][Full Text] [Related]
8. Exaggerated response of adrenocorticotropic hormone to growth hormone-releasing peptide-2 test in Cushing's disease. Case report.
Sakihara S; Kageyama K; Matsumoto A; Ikeda H; Tsushima Y; Naraoka M; Terui K; Nigawara T; Suda T
Neurol Med Chir (Tokyo); 2009 Aug; 49(8):365-9. PubMed ID: 19707004
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.
Cannavò S; Almoto B; Dall'Asta C; Corsello S; Lovicu RM; De Menis E; Trimarchi F; Ambrosi B
Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521
[TBL] [Abstract][Full Text] [Related]
10. Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas.
Selvais P; Donckier J; Buysschaert M; Maiter D
Eur J Endocrinol; 1998 Feb; 138(2):153-9. PubMed ID: 9506858
[TBL] [Abstract][Full Text] [Related]
11. Periodic secretion of adrenocorticotropin in a patient with Cushing's disease manifested during pregnancy.
Miyoshi T; Otsuka F; Suzuki J; Inagaki K; Takeda M; Kano Y; Yamashita T; Ogura T; Date I; Tanaka Y; Hashimoto K; Makino H
Endocr J; 2005 Jun; 52(3):287-92. PubMed ID: 16006722
[TBL] [Abstract][Full Text] [Related]
12. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
13. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
Colombo P; Passini E; Re T; Faglia G; Ambrosi B
Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
[TBL] [Abstract][Full Text] [Related]
14. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
Schweikert HU; Fehm HL; Fahlbusch R; Martin R; Kolloch R; Higuchi M; Krück F
Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical response to dexamethasone and spontaneous hypocortisolism in Cushing's disease.
Lila AR; Sarathi V; Bandgar TR; Shah NS
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23365169
[TBL] [Abstract][Full Text] [Related]
16. Potential utility of FLAIR in MRI-negative Cushing's disease.
Chatain GP; Patronas N; Smirniotopoulos JG; Piazza M; Benzo S; Ray-Chaudhury A; Sharma S; Lodish M; Nieman L; Stratakis CA; Chittiboina P
J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO
Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China.
Zhang K; Shen M; Qiao N; Chen Z; He W; Ma Z; Shou X; Li S; Zhao Y; Pan L; Liu D; He M; Zhang Z; Li Y; Yao Z; Ye H; Wang Y
Neurosurg Focus; 2020 Jun; 48(6):E7. PubMed ID: 32480378
[TBL] [Abstract][Full Text] [Related]
19. Endogenous ACTH concentration-cortisol secretion dose analysis unmasks decreased ACTH potency in Cushing's disease with restoration after successful pituitary adenomectomy.
Roelfsema F; Keenan DM; Veldhuis JD
J Clin Endocrinol Metab; 2011 Dec; 96(12):3768-74. PubMed ID: 21917875
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas.
Blevins LS; Christy JH; Khajavi M; Tindall GT
J Clin Endocrinol Metab; 1998 Jan; 83(1):63-7. PubMed ID: 9435417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
